Stock Analysis

Gabriel India First Quarter 2026 Earnings: EPS: ₹4.31 (vs ₹4.01 in 1Q 2025)

NSEI:GABRIEL
Source: Shutterstock
Advertisement

Gabriel India (NSE:GABRIEL) First Quarter 2026 Results

Key Financial Results

  • Revenue: ₹11.0b (up 17% from 1Q 2025).
  • Net income: ₹619.7m (up 7.6% from 1Q 2025).
  • Profit margin: 5.6% (down from 6.1% in 1Q 2025). The decrease in margin was driven by higher expenses.
  • EPS: ₹4.31 (up from ₹4.01 in 1Q 2025).
earnings-and-revenue-growth
NSEI:GABRIEL Earnings and Revenue Growth July 31st 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

Gabriel India Earnings Insights

Looking ahead, revenue is forecast to grow 9.7% p.a. on average during the next 2 years, compared to a 9.0% growth forecast for the Auto Components industry in India.

Performance of the Indian Auto Components industry.

The company's shares are up 4.4% from a week ago.

Risk Analysis

You still need to take note of risks, for example - Gabriel India has 2 warning signs (and 1 which is a bit unpleasant) we think you should know about.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.